CTIS2023-509457-31-00进行中（未招募）1 期
Study of Pembrolizumab combined with Ataluren in Patients with metastatic pMMR and dMMR colorectal cancer adenocarcinomas or metastatic dMMR endometrial carcinoma: the ATAPEMBRO study
Amsterdam UMC0 个研究点目标入组 47 人开始时间: 2024年5月8日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 47
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Combining Ataluren with immunotherapy for the treatment of colorectal and endometrial cancer: the ATAPEMBRO study.Mismatch repair deficient and proficient metestatic colorectal carcinoma and mismatch repair deficient metastatic endometrial carcinomaEUCTR2017-004752-34-NLAmsterdam University Medical Centers location AMC47
招募中
2 期
Study of pembrolizumab combined with ataluren in Patients with metastatic pMMR and dMMR colorectal cancer adenocarcinomas or metastatic dMMR endometrial carcinoma: the ATAPEMBRO study.advanced cancer of the colonmetastastic colon cancer10027476NL-OMON55845Academisch Medisch Centrum47
尚未招募
不适用
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMRColorectal Cacrinoma or Metastatic dMMR Endometrial Carcinoma: theATAPEMBRO Study.NL-OMON23548Amsterdam UMC location AMC47
招募中
1 期
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO StudyEndometrium CancerColorectal CancerNCT04014530Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)47
进行中（未招募）
2 期
A phase 2 study of pembrolizumab in combination with olaparib in patients with cervical cancer previously treated with platinum-based chemotherapyrecurrent or metastatic cervical cancercervical cancer ,Pembrolizumab,OlaparibJPRN-jRCT2031210096Hasegawa Kosei28